Charles Schwab’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-28,661
| Closed | -$527K | – | 3541 |
|
|
2020
Q4 | $527K | Hold |
28,661
| – | – | ﹤0.01% | 2973 |
|
|
2020
Q3 | $526K | Sell |
28,661
-1,074
| -4% | -$19.7K | ﹤0.01% | 2863 |
|
|
2020
Q2 | $446K | Buy |
29,735
+1,209
| +4% | +$18.1K | ﹤0.01% | 2882 |
|
|
2020
Q1 | $452K | Hold |
28,526
| – | – | ﹤0.01% | 2748 |
|
|
2019
Q4 | $464K | Hold |
28,526
| – | – | ﹤0.01% | 2845 |
|
|
2019
Q3 | $424K | Hold |
28,526
| – | – | ﹤0.01% | 2867 |
|
|
2019
Q2 | $472K | Buy |
28,526
+3,323
| +13% | +$55K | ﹤0.01% | 2837 |
|
|
2019
Q1 | $437K | Buy |
25,203
+703
| +3% | +$12.2K | ﹤0.01% | 2808 |
|
|
2018
Q4 | $433K | Hold |
24,500
| – | – | ﹤0.01% | 2821 |
|
|
2018
Q3 | $445K | Buy |
24,500
+2,900
| +13% | +$52.7K | ﹤0.01% | 2883 |
|
|
2018
Q2 | $423K | Buy |
+21,600
| New | +$423K | ﹤0.01% | 2851 |
|
|
2017
Q2 | – | Sell |
-22,709
| Closed | -$268K | – | 3167 |
|
|
2017
Q1 | $268K | Hold |
22,709
| – | – | ﹤0.01% | 2856 |
|
|
2016
Q4 | $298K | Hold |
22,709
| – | – | ﹤0.01% | 2852 |
|
|
2016
Q3 | $330K | Hold |
22,709
| – | – | ﹤0.01% | 2753 |
|
|
2016
Q2 | $273K | Buy |
22,709
+8,400
| +59% | +$101K | ﹤0.01% | 2817 |
|
|
2016
Q1 | $267K | Hold |
14,309
| – | – | ﹤0.01% | 2808 |
|
|
2015
Q4 | $308K | Hold |
14,309
| – | – | ﹤0.01% | 2851 |
|
|
2015
Q3 | $243K | Hold |
14,309
| – | – | ﹤0.01% | 2907 |
|
|
2015
Q2 | $537K | Buy |
+14,309
| New | +$537K | ﹤0.01% | 2649 |
|